Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Adrian Day: Gold Stock Setup is “Perfect,” Waiting on the West

by admin February 2, 2025
February 2, 2025
Adrian Day: Gold Stock Setup is “Perfect,” Waiting on the West

He sees the setup for gold equities as ‘perfect,’ but said most western investors aren’t interested.

That’s because — particularly in the US — there’s a belief that the economy and stock market are strong, inflation is under control and the Trump administration will make all of these elements even better.

‘The narrative at the moment is just not favorable to gold investing — that will change, and I think it’ll change … when the stock market rolls over, and when it’s obvious that the economy is slowing,’ he said.

Watch the interview above for more of Day’s thoughts on gold, as well as gold stocks. You can also click here to view our Vancouver Resource Investment Conference playlist on YouTube.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
WNBA files trademark application to bring back ‘Detroit Shock’ as city submits expansion bid
next post
House GOP elections chair reveals which voter blocs Republicans are targeting ahead of 2026

Related Posts

Syntheia Announces First 1,000 Subscriptions

February 15, 2025

Cizzle Brands Strengthens U.S. Footprint of CWENCH Hydration...

April 11, 2025

Top 5 Canadian Silver Stocks of 2025

April 14, 2025

NorthStar Gaming Announces Receipt of Management Cease Trade...

May 9, 2025

Crypto Market Recap: US Crypto Legislation “Imminent,” Coinbase...

March 20, 2025

Takeover Update – Offer Declared Best and Final

March 17, 2025

Ulytau Project Exploration Licence Granted

March 19, 2025

Trillion Energy Announces SASB Field Operational Update

February 14, 2025

Kingsrose-BHP Alliances Announce High Grade Rockchips and Provide...

January 30, 2025

Coelacanth Announces Q4 2024 Financial and Operating Results

April 24, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved